• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

逆行超选择性动脉内化学放射治疗联合热疗和西妥昔单抗治疗伴有 N3 淋巴结转移的颊黏膜癌:病例报告。

Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report.

机构信息

Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.

Department of Oral and Maxillofacial Surgery, Niigata Hospital, The Nippon Dental University, 1-8 Hamauracho, Chuo-ku, Niigata, 951-8580, Japan.

出版信息

Oral Radiol. 2019 Jan;35(1):77-83. doi: 10.1007/s11282-018-0319-y. Epub 2018 Feb 5.

DOI:10.1007/s11282-018-0319-y
PMID:30484180
Abstract

We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m and cisplatin, total of 175 mg/m), cetuximab (initial dose of 400 mg/m with subsequent weekly doses of 250 mg/m intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor. Radical neck dissection was performed with reconstructive surgery, including resection of the overlying skin. A pathologic complete response was achieved for the N3 and all other cervical lymph node metastases. The patient showed no evidence of recurrence in the 3 years following treatment. Based on the findings in the present case, the use of retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab seems to be a promising modality for patients with N3 cervical lymph node metastasis of oral cancer.

摘要

我们在此报告一例 63 岁男性颊黏膜鳞状细胞癌伴 N3 颈淋巴结转移病例。该患者接受了联合治疗,包括放疗(2 Gy/天,总量 70 Gy)、经颞浅动脉超选择性动脉内化疗(多西他赛,总量 70 mg/m2 及顺铂,总量 175 mg/m2)、西妥昔单抗(初始剂量 400 mg/m2,随后每周静脉内给予 250 mg/m2)和 4 次颈部淋巴结转移的高热治疗。患者对治疗反应良好,原发肿瘤完全缓解。行根治性颈淋巴结清扫术,并进行了包括皮肤切除的重建手术。N3 和所有其他颈部淋巴结转移均达到病理完全缓解。治疗后 3 年患者未出现复发迹象。基于本病例的发现,逆行超选择性动脉内放化疗联合高热和西妥昔单抗治疗似乎是口腔癌 N3 颈淋巴结转移患者的一种有前途的治疗方法。

相似文献

1
Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report.逆行超选择性动脉内化学放射治疗联合热疗和西妥昔单抗治疗伴有 N3 淋巴结转移的颊黏膜癌:病例报告。
Oral Radiol. 2019 Jan;35(1):77-83. doi: 10.1007/s11282-018-0319-y. Epub 2018 Feb 5.
2
Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.采用超选择性经颞浅动脉和枕动脉动脉内灌注热化疗治疗伴有颈 N3 转移的口腔癌。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e639-45. doi: 10.1016/j.ijrobp.2012.02.057. Epub 2012 Apr 28.
3
Thermochemoradiotherapy using superselective intra-arterial infusion for N3 cervical lymph node metastases of tongue cancer.采用超选择性动脉内灌注的热化学放疗治疗舌癌N3期颈部淋巴结转移
J Cancer Res Ther. 2013 Oct-Dec;9(4):718-20. doi: 10.4103/0973-1482.126465.
4
Thermochemoradiotherapy Using Superselective Intra-arterial Infusion for Patients With Oral Cancer With Cervical Lymph Node Metastases.超选择性动脉内灌注热化疗放疗用于治疗伴有颈部淋巴结转移的口腔癌患者
Anticancer Res. 2019 Mar;39(3):1365-1373. doi: 10.21873/anticanres.13250.
5
Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas.同期逆行超选择性动脉内灌注化疗联合西妥昔单抗治疗同步多发口腔鳞癌的疗效。
Radiat Oncol. 2023 May 26;18(1):90. doi: 10.1186/s13014-023-02282-9.
6
Prognostic evaluation of preoperative thermochemoradiotherapy for N(3) cervical lymph node metastases of oral cancer.口腔癌N(3) 期颈部淋巴结转移术前热化疗放疗的预后评估
Oncology. 2002;62(3):234-40. doi: 10.1159/000059571.
7
Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.逆行超选择性动脉内化疗联合每日同步放疗治疗Ⅲ期和Ⅳ期口腔癌:112例治疗结果分析
Radiother Oncol. 2014 May;111(2):306-10. doi: 10.1016/j.radonc.2014.03.005. Epub 2014 Apr 17.
8
Effectiveness of superselective intra-arterial chemoradiotherapy targeting retropharyngeal lymph node metastasis.针对咽后淋巴结转移的超选择性动脉内放化疗的有效性
Eur Arch Otorhinolaryngol. 2016 Oct;273(10):3331-6. doi: 10.1007/s00405-016-3933-5. Epub 2016 Feb 13.
9
Antitumor effects on primary tumor and metastatic lymph nodes by superselective intra-arterial concurrent chemoradiotherapy for oral cancer.超选择性动脉内同步放化疗对口腔癌原发肿瘤及转移性淋巴结的抗肿瘤作用。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Aug;110(2):172-7. doi: 10.1016/j.tripleo.2009.12.040. Epub 2010 Apr 9.
10
[The efficacy of superselective intra-arterial chemo-radiotherapy for cervical neck lymph node metastases].[超选择性动脉内化疗放疗对颈部淋巴结转移瘤的疗效]
Nihon Jibiinkoka Gakkai Kaiho. 2014 Jun;117(6):794-801. doi: 10.3950/jibiinkoka.117.794.

引用本文的文献

1
The ECAS system can superselectively administer anticancer drugs to numerous feeding arteries from the superficial temporal artery: A case report and literature review.ECAS系统可超选择性地向颞浅动脉的众多供血动脉给予抗癌药物:一例病例报告及文献综述。
Mol Clin Oncol. 2023 Aug 10;19(4):76. doi: 10.3892/mco.2023.2672. eCollection 2023 Oct.
2
Systematic review about complementary medical hyperthermia in oncology.系统评价补充医学热疗在肿瘤学中的应用。
Clin Exp Med. 2022 Nov;22(4):519-565. doi: 10.1007/s10238-022-00846-9. Epub 2022 Jun 29.
3
Efficacy and Safety of Intro-Arterial Chemotherapy Combined with Radiotherapy on Head and Neck Cancer: A Systematic Review and Meta-Analysis.

本文引用的文献

1
A retrospective analysis of patients with head and neck cancer treated with radiation, hyperthermia, and cetuximab: A brief report of outcome.对头颈部癌患者采用放疗、热疗和西妥昔单抗治疗的回顾性分析:疗效简要报告
J Cancer Res Ther. 2016 Jul-Sep;12(3):1164-1166. doi: 10.4103/0973-1482.194600.
2
Cetuximab for the treatment of locally advanced and recurrent/metastatic oral cancer: An investigation of distant metastasis.西妥昔单抗治疗局部晚期及复发/转移性口腔癌:远处转移的研究
Mol Clin Oncol. 2016 Aug;5(2):246-252. doi: 10.3892/mco.2016.928. Epub 2016 Jun 13.
3
HPV16 infection in oral cavity and oropharyngeal cancer patients.
动脉内化疗联合放疗治疗头颈癌的疗效与安全性:一项系统评价与Meta分析
J Cancer. 2019 Oct 17;10(25):6233-6243. doi: 10.7150/jca.36478. eCollection 2019.
口腔和口咽癌患者中的人乳头瘤病毒16型感染
J Oral Sci. 2016;58(2):265-9. doi: 10.2334/josnusd.15-0629.
4
Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.逆行超选择性动脉内化疗联合每日同步放疗治疗Ⅲ期和Ⅳ期口腔癌:112例治疗结果分析
Radiother Oncol. 2014 May;111(2):306-10. doi: 10.1016/j.radonc.2014.03.005. Epub 2014 Apr 17.
5
Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.采用超选择性经颞浅动脉和枕动脉动脉内灌注热化疗治疗伴有颈 N3 转移的口腔癌。
Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):e639-45. doi: 10.1016/j.ijrobp.2012.02.057. Epub 2012 Apr 28.
6
Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.采用超选择性颞浅动脉内动脉灌注每日同步放化疗保肢治疗 T3 和 T4 头颈部癌症。
Int J Radiat Oncol Biol Phys. 2011 Apr 1;79(5):1428-35. doi: 10.1016/j.ijrobp.2010.01.011. Epub 2010 Jun 3.
7
Hyperthermia adds to chemotherapy.热疗辅助化疗。
Eur J Cancer. 2008 Nov;44(17):2546-54. doi: 10.1016/j.ejca.2008.07.038. Epub 2008 Sep 11.
8
Platinum-based chemotherapy plus cetuximab in head and neck cancer.铂类化疗联合西妥昔单抗治疗头颈癌。
N Engl J Med. 2008 Sep 11;359(11):1116-27. doi: 10.1056/NEJMoa0802656.
9
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.在一项前瞻性临床试验中,人乳头瘤病毒阳性头颈部鳞状细胞癌患者的生存率提高。
J Natl Cancer Inst. 2008 Feb 20;100(4):261-9. doi: 10.1093/jnci/djn011. Epub 2008 Feb 12.
10
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.放疗联合西妥昔单抗治疗头颈部鳞状细胞癌。
N Engl J Med. 2006 Feb 9;354(6):567-78. doi: 10.1056/NEJMoa053422.